TAFFA N TMUSNIWIN TUSNANIN

2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

American Association of Clinical EndocrinologyTasleḍt n tfeggagin d ssker2022Asuffeɣ unṣib

Agzul n yisemli ASEM

Official American Association of Clinical Endocrinology document (2022) on “2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings”. This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders. DOI: 10.1016/j.eprac.2022.03.010.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib